TrialBMJ open respiratory research2021

TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis.

John A Mackintosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.